Supernus Pharmaceuticals Inc
F:S49
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Supernus Pharmaceuticals Inc
F:S49
|
US |
|
D
|
Dental Corporation PCL
SET:D
|
TH |
|
Kingfisher PLC
F:KFI1
|
UK |
|
Grupo Aeroportuario del Sureste SAB de CV
F:AED
|
MX |
Wall St Price Targets
S49 Price Targets Summary
Supernus Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for S49 is 57.36 EUR with a low forecast of 49.85 EUR and a high forecast of 62.19 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is S49's stock price target?
Price Target
57.36
EUR
According to Wall Street analysts, the average 1-year price target for S49 is 57.36 EUR with a low forecast of 49.85 EUR and a high forecast of 62.19 EUR.
What is the Revenue forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 63%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for Supernus Pharmaceuticals Inc?
Projected CAGR
62%
The compound annual growth rate for Operating Income over the next 8 years is 62%.
